Related Experiment Videos
Efficacy of acyclovir against mouse cytomegalovirus in vivo
Antimicrobial Agents and Chemotherapy
|August 1, 1981
Abstract:
Acyclovir reduced mortality and organ virus titers in mice inoculated intraperitoneally with 10 50% lethal doses of mouse cytomegalovirus. This susceptibility to acyclovir of a herpesvirus which lacks thymidine kinase is surprising. Alternative phosphorylating enzymes may account for this susceptibility.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy.
Clinical pharmacology and therapeutics·2016
Secondary solid cancer screening following hematopoietic cell transplantation.
Bone marrow transplantation·2015
In vitro activity of zosurabalpin against a global set of carbapenem-resistant-A. baumannii clinical isolates.
Antimicrobial agents and chemotherapy·2026
N-terminal lysine as a critical determinant of odilorhabdin susceptibility to inactivation by the self-resistance acetyltransferase OatA.
Antimicrobial agents and chemotherapy·2026
Amphotericin B resistance in Lomentospora prolificans is associated with a soluble cell wall component.
Antimicrobial agents and chemotherapy·2026
Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein.
Antimicrobial agents and chemotherapy·2026
In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.
Antimicrobial agents and chemotherapy·2026
Confounding by indication in the evaluation of neoadjuvant chemotherapy: a sequential Cox analysis of an eight-year single-centre breast cancer cohort.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Anti-angiogenic therapy in thymic carcinoma: a narrative review of current evidence and emerging combinations.
Mediastinum (Hong Kong, China)·2026
Narrative review: locally advanced thymoma-do we really need induction therapy before extended resection?
Mediastinum (Hong Kong, China)·2026